Have a symptom?
See what questions
a doctor would ask.

Pompe disease

Pompe disease: Introduction

Pompe disease: A rare inherited biochemical disorder where insufficient maltase acid results in accumulation of glycogen. The condition is often fatal in infants, causes mental retardation, hypotonia and a short life in children and progressive muscle weakness in adults. Also called glycogen storage disease type II. More detailed information about the symptoms, causes, and treatments of Pompe disease is available below.

Symptoms of Pompe disease

Wrongly Diagnosed with Pompe disease?

Pompe disease: Deaths

Read more about Deaths and Pompe disease.

Pompe disease: Complications

Review possible medical complications related to Pompe disease:

Causes of Pompe disease

Read more about causes of Pompe disease.

Disease Topics Related To Pompe disease

Research the causes of these diseases that are similar to, or related to, Pompe disease:

Pompe disease: Research Doctors & Specialists

Research related physicians and medical specialists:

Other doctor, physician and specialist research services:

Evidence Based Medicine Research for Pompe disease

Medical research articles related to Pompe disease include:

Click here to find more evidence-based articles on the TRIP Database

Pompe disease: Animations

Research about Pompe disease

Visit our research pages for current research about Pompe disease treatments.

Statistics for Pompe disease

Pompe disease: Broader Related Topics

User Interactive Forums

Read about other experiences, ask a question about Pompe disease, or answer someone else's question, on our message boards:

Definitions of Pompe disease:

An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE DEFICIENCY. Large amounts of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4) - (Source - Diseases Database)

Pompe disease is listed as a "rare disease" by the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH). This means that Pompe disease, or a subtype of Pompe disease, affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)

Ophanet, a consortium of European partners, currently defines a condition rare when it affects 1 person per 2,000. They list Pompe disease as a "rare disease".
Source - Orphanet

Related Pompe disease Info

More information about Pompe disease

  1. Pompe disease: Introduction
  2. Symptoms
  3. Causes
  4. Treatments
  5. Deaths
  6. Complications

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise